Spots Global Cancer Trial Database for US Selumetinib Registry

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: US Selumetinib Registry

Official Title: US Selumetinib Registry

Study ID: NCT05683678

Conditions

Neurofibromatosis Type 1

Plexiform Neurofibromas

Interventions

Study Description

Brief Summary: The purpose of this study is to understand treatment patterns and assess long-term effectiveness and safety outcomes associated with selumetinib treatment as well as to explore clinical and non-clinical factors affecting those outcomes in participants with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PNs) who were aged 2 to 18 years at the time selumetinib was started in a real-world setting.

Detailed Description: This is a US observational registry of pediatric NF1 PN participants treated with selumetinib.